Eli Lilly | LLY - EPS Earnings Per Share


Eli Lilly reported $8.38 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 9.46 7.02 Oct/29
FY2026Q2 Jun/2026 8.38 8.82 6.31 Aug/05
FY2026Q1 Mar/2026 8.55 7.25 3.34 Apr/30
FY2025Q4 Dec/2025 7.54 7.16 5.32 Feb/04
FY2025Q3 Sep/2025 7.02 6.36 1.18 Oct/30




Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Abbott USD 1.31 0.16 Jun/2026
ALKERMES USD 0 0.4 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Baxter International USD 0.56 0.2 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Drreddys Laboratories INR 0.06 0.1 Mar/2026
Eli Lilly USD 8.38 0.17 Jun/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
J&J USD 2.9 0.2 Jun/2026
Medtronic USD 1.55 0.19 Mar/2026
Merck USD -0.13 1.15 Jun/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Novartis USD 1.99 0.45 Mar/2026
Novo Nordisk DKK 4.74 6.17 Jun/2026
Perrigo USD 0.5 0.07 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 0.98 0.25 Jun/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 2.09 0.21 Jun/2026
Sanofi EUR 2.17 2.84 Mar/2026
United Therapeutics USD 7.27 1.45 Jun/2026
Zoetis USD 1.87 0.34 Jun/2026